The risk and severity of stroke in patients with atrial fibrillation and gout: A National Representative Database

Faris Haddadin1, Ana B Arevalo2, Ahmad Jabri3

  • 1Section of Cardiology Baylor College of Medicine Houston TX USA.

Journal of Arrhythmia
|April 14, 2021
PubMed

Insights

Gout increases the risk of new stroke in patients with atrial fibrillation (AF). However, gout presence did not affect stroke severity in AF patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Neurology

Background:

  • Gout is linked to left atrium remodeling and inflammation, contributing to atrial fibrillation (AF).
  • Limited evidence exists on gout's impact on stroke risk in AF patients.

Purpose of the Study:

  • To assess the incidence of gout and its association with stroke risk in patients diagnosed with AF.

Main Methods:

  • Retrospective cohort study utilizing the 2016 US National Inpatient Sample (NIS).
  • Analysis based on ICD-10 codes to identify patients with AF and gout.
  • Outcomes measured included the risk and severity of new stroke.

Main Results:

  • Over 3.8 million patients with AF were identified, with 240,875 having a history of gout.
  • Patients with AF and gout exhibited a significantly higher risk of new stroke (OR 2.07, P < .001).
  • This elevated stroke risk persisted after adjusting for CHADS2VASC score and other comorbidities (OR 1.10, P = .041). Gout did not correlate with mortality or need for mechanical ventilation.

Conclusions:

  • Gout is associated with an increased risk of new stroke in patients with AF.
  • Gout presence was not linked to stroke severity in this patient cohort.
  • Gout may serve as a risk factor or marker for stroke in individuals with AF.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
197
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
98
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
141
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
100
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
130
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
100